VASER Treatment of Axillary Hyperhidrosis/Bromidrosis (VASER AxHH)

Commons Aesthetic Plastic Surgery

Status and phase

Completed

Phase 4

Conditions

Axillary Hyperhidrosis

Treatments

Device: VASER

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT00735293

VASER AxHH

Details and patient eligibility

About

Patients with excessive underarm odor and sweating and/or odor are treated with the VASER system to determine the VASER's effectiveness in reducing underarm sweat and odor

Full description

Patients with excessive underarm sweat and/or odor are recruited. The effect that excessive underarm sweat and/or odor has on their lifestyle is evaluated. They are surgically treated with the VASER system and followed up for 6 months to evaluate side effects, adverse events and effectiveness. Additional lifestyle evaluations are completed for comparison to pre-surgery answers.

Enrollment

13 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

18 years or older
Willing and able to appear for all scheduled, post-operative visits
Have axillary hyperhidrosis/bromidrosis that does not respond to conventional, non-invasive treatment

Exclusion criteria

under the age of 18
have undergone a prior surgical intervention for treatment of axillary hyperhidrosis (e.g.) Skoog procedure, ETS)
have been treated with a systemic or topical agent for axillary hyperhidrosis in the past 30 days
are deemed inappropriate candidates for surgery due to medical or mental health reasons
are currently being treated with investigational agents or have participated in an investigational study within 60 days prior to surgery
elect not to participate in the study